Biggest News Aggregation in the World
📰 Major Amendment News

Major Amendment News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Major Amendment. Real-time updates on events, politics, business and more.

FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease - Applied Therapeutics (NASDAQ:APLT)

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The new action date is set for November 28, 2024. Applied Therapeutics anticipates a decision from EMA in Q4 2024.
Committee For Medicinal Products Human Use Therapeutics Inc Applied Therapeutics Inc Drug Application Classic Galactosemia Prescription Drug User Fee Act

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

NEW YORK, March 28, 2024 -- Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications...
Advanz Pharma Maeve Conneighton Shoshana Shendelman Exchange Commission Committee For Medicinal Products Human Use European Medicines Agency

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science